Akzo Nobel N.V. Logo

Akzo Nobel N.V.

ISIN: NL0013267909 | LEI: 724500XYIJUGXAA5QD70
Sector: MaterialsSub-Industry: Specialty Chemicals
Country: Netherlands

About Akzo Nobel N.V.

Company Description

We’re in a unique position to show how passionately we care about society, the world we live in and making new discoveries. By using the transformative power of paints and coatings, we can deliver the sustainable and innovative solutions that our customers, communities – and the planet – are increasingly relying on.

Our world class portfolio of brands – including Dulux, International, Sikkens and Interpon – is trusted by customers around the globe. We’re active in more than 150 countries and have set our sights on becoming the global industry leader. It’s what you’d expect from a pioneering paints company that’s committed to science-based targets and is taking genuine action to address globally relevant challenges and protect future generations. For more information please visit www.akzonobel.com

Year founded

1792

Served area

Worldwide

Headquarters

Christian Neefestraat 2, 1077 Amsterdam – Netherlands

Financial statements

Download as Excel
Line item in (eur) 01.01.2020 01.01.2021 01.01.2022 01.01.2023
Assets N/A 13,177,000,000.00 13,878,000,000.00 14,741,000,000.00
Noncurrent Assets N/A 8,113,000,000.00 8,530,000,000.00 8,497,000,000.00
Property Plant And Equipment N/A 1,621,000,000.00 1,800,000,000.00 1,968,000,000.00
Investments In Subsidiaries Joint Ventures And Associates N/A 166,000,000.00 178,000,000.00 193,000,000.00
Deferred Tax Assets N/A 497,000,000.00 482,000,000.00 498,000,000.00
Other Noncurrent Financial Assets N/A 1,951,000,000.00 2,076,000,000.00 1,475,000,000.00
Current Assets N/A 5,064,000,000.00 5,348,000,000.00 6,244,000,000.00
Inventories N/A 1,159,000,000.00 1,650,000,000.00 1,843,000,000.00
Trade And Other Current Receivables N/A 1,994,000,000.00 2,339,000,000.00 2,447,000,000.00
Current Tax Assets Current N/A 55,000,000.00 149,000,000.00 168,000,000.00
Other Current Financial Assets N/A 250,000,000.00 58,000,000.00 N/A
Cash and cash equivalents N/A 1,606,000,000.00 1,152,000,000.00 1,450,000,000.00
Equity And Liabilities N/A 13,177,000,000.00 13,878,000,000.00 14,741,000,000.00
Equity 6,568,000,000.00 5,950,000,000.00 5,636,000,000.00 4,548,000,000.00
Equity Attributable To Owners Of Parent N/A 5,746,000,000.00 5,425,000,000.00 4,333,000,000.00
Noncontrolling Interests N/A 204,000,000.00 211,000,000.00 215,000,000.00
Noncurrent Liabilities N/A 4,134,000,000.00 3,373,000,000.00 4,447,000,000.00
Noncurrent Provisions For Employee Benefits N/A 664,000,000.00 578,000,000.00 387,000,000.00
Other Longterm Provisions N/A 232,000,000.00 234,000,000.00 167,000,000.00
Deferred Tax Liabilities N/A 467,000,000.00 567,000,000.00 561,000,000.00
Longterm Borrowings N/A 2,771,000,000.00 1,994,000,000.00 3,332,000,000.00
Current Liabilities N/A 3,093,000,000.00 4,869,000,000.00 5,746,000,000.00
Current Provisions N/A 232,000,000.00 149,000,000.00 166,000,000.00
Trade And Other Current Payables N/A 2,580,000,000.00 2,948,000,000.00 2,801,000,000.00
Current Tax Liabilities Current N/A 162,000,000.00 216,000,000.00 236,000,000.00
Line item in (eur) 01.01.2020/
01.01.2021
01.01.2021/
01.01.2022
01.01.2022/
01.01.2023
Revenue 8,530,000,000.00 9,587,000,000.00 10,846,000,000.00
Other Gains Losses -5,000,000.00 67,000,000.00 0.00
Profit Loss From Operating Activities 963,000,000.00 1,118,000,000.00 708,000,000.00
Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method 25,000,000.00 26,000,000.00 18,000,000.00
Profit Loss Before Tax 919,000,000.00 1,105,000,000.00 602,000,000.00
Income Tax Expense Continuing Operations 241,000,000.00 246,000,000.00 214,000,000.00
Profit Loss From Continuing Operations 678,000,000.00 859,000,000.00 388,000,000.00
Profit Loss From Discontinued Operations -7,000,000.00 6,000,000.00 -10,000,000.00
Profit (loss) 671,000,000.00 865,000,000.00 378,000,000.00
Profit Loss Attributable To Owners Of Parent 630,000,000.00 829,000,000.00 352,000,000.00
Profit Loss Attributable To Noncontrolling Interests 41,000,000.00 36,000,000.00 26,000,000.00
Line item in (eur) 01.01.2021 01.01.2022 01.01.2023
Profit (loss) 671,000,000.00 865,000,000.00 378,000,000.00
Adjustments For Income Tax Expense 241,000,000.00 246,000,000.00 214,000,000.00
Adjustments For Depreciation And Amortisation Expense 361,000,000.00 351,000,000.00 368,000,000.00
Adjustments For Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss 10,000,000.00 3,000,000.00 6,000,000.00
Adjustments For Undistributed Profits Of Associates 25,000,000.00 26,000,000.00 18,000,000.00
Other Adjustments To Reconcile Profit Loss 9,000,000.00 -23,000,000.00 30,000,000.00
Interest Paid Classified As Operating Activities 47,000,000.00 77,000,000.00 78,000,000.00
Income Taxes Paid Refund Classified As Operating Activities 165,000,000.00 222,000,000.00 224,000,000.00
Cash Flows From Used In Operating Activities 1,220,000,000.00 605,000,000.00 263,000,000.00
Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities 113,000,000.00 73,000,000.00 588,000,000.00
Interest Received Classified As Investing Activities 8,000,000.00 10,000,000.00 14,000,000.00
Other Inflows Outflows Of Cash Classified As Investing Activities 0.00 -1,000,000.00 -2,000,000.00
Cash Flows From Used In Investing Activities -427,000,000.00 -134,000,000.00 -1,095,000,000.00
Payments From Changes In Ownership Interests In Subsidiaries 44,000,000.00 1,000,000.00 0.00
Payments To Acquire Or Redeem Entitys Shares 555,000,000.00 1,135,000,000.00 669,000,000.00
Repayments Of Borrowings Classified As Financing Activities 339,000,000.00 590,000,000.00 7,322,000,000.00
Dividends Paid Classified As Financing Activities 385,000,000.00 391,000,000.00 379,000,000.00
Cash Flows From Used In Financing Activities -353,000,000.00 -974,000,000.00 1,141,000,000.00
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes 437,000,000.00 -503,000,000.00 309,000,000.00
Effect Of Exchange Rate Changes On Cash And Cash Equivalents -66,000,000.00 35,000,000.00 -14,000,000.00
Cash and cash equivalents 1,606,000,000.00 1,152,000,000.00 1,450,000,000.00

Please note that some sums might not add up.

Filings & Publications

2022

Report
Q1
H1
Q3
FY
Consolidated Report
ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2021

Report
Q1
H1
Q3
FY
Consolidated Report
ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

Insider Trades

Date Trading entity / Person Association Trade type Volume
26.04.23 G. Poux-Guillaume Executive member Buy EUR 7,730,986.00
26.04.23 M. de Vries Executive member Buy EUR 5,853,672.00
21.02.23 B. Grote Non-Executive member Buy USD 24,650.00
21.02.23 B. Grote Non-Executive member Buy USD 12,300.00
23.08.22 B. Grote Non-Executive member Buy USD 43,380.00
21.04.22 M. de Vries Executive member Buy EUR 110,920.20
02.03.22 M. de Vries Executive member Sell EUR 359,771.48
02.03.22 M. de Vries Executive member Other EUR 0.00
28.02.22 M. de Vries Non-Executive member Buy EUR 62,831.85
30.11.21 B. Grote Non-Executive member Buy USD 7,070.00

Short Interest


Current short interest

Position Holder Short Interest in Percent Date
Marshall Wace LLP 0.50% 04.12.23
AKO Capital LLP 0.51% 19.03.24
Total 1.01%

Capital markets information

ISIN

NL0013267909

LEI

724500XYIJUGXAA5QD70

Sector

Materials

Industry Group

Materials

Industry

Chemicals

Sub-Industry

Specialty Chemicals

Listed Stock Exchange

Euronext Amsterdam

Stock Index

AEX

Main Stock Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.